1.Effects of combined use of total alkaloids of Uncaria rhynchophylla and Coryadlis ambailis migo on cerebral ischemia-reperfusion injury in rats.
Xue-yong HU ; An-sheng SUN ; Yu-xia SUI
Chinese Journal of Integrated Traditional and Western Medicine 2007;27(11):1007-1009
OBJECTIVETo study the effects of combined use of total alkaloids (TA) of Uncaria rhynchophylla (UR) and Coryadlis ambailis migo (CAM) on cerebral ischemia/reperfusion injury in rats.
METHODSRat model of middle cerebral artery ischemia/reperfusion was established, the changes of neurological state was scored before and after treatment with the two kinds of TA, single or combined, and the changes of cerebral infarcted volume, cerebral water content, activities of NOS and SOD and content of MDA in rats' brain were estimated as well.
RESULTSAfter being treated with the combination of both TA, the average neurological score, cerebral infracted volume, cerebral water content, activity of NOS and content of MDA in the model rats significantly decreased, and the activity of SOD was significantly increased (all P < 0.05). The effect of combined use of the two TA was higher than that of use TA of UR or CAM alone (P <0.05). Moreover, the central nervous system inhibitory effect induced by combined TA was significantly weaker than that of UR.
CONCLUSIONCombined use of TA of UR and CAM may facilitate the protection against cerebral ischemia/reperfusion damage, the action mechanism might be relevant to reducing the lipid peroxidation injury of brain cells through inhibiting the NOS activity and increasing the SOD activity.
Alkaloids ; pharmacology ; therapeutic use ; Animals ; Brain ; blood supply ; drug effects ; enzymology ; Brain Ischemia ; complications ; Corydalis ; chemistry ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Female ; Male ; Mice ; Neuroprotective Agents ; pharmacology ; therapeutic use ; Nitric Oxide Synthase Type I ; metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury ; etiology ; prevention & control ; Superoxide Dismutase ; metabolism ; Uncaria ; chemistry
2.Effect of cyclosporine and simulect mono and combination therapy on cardiac allo-transplantation in rats.
Hai-Bo XIONG ; Sui-Sheng XIA ; Zu-Fal HUANG ; Qi-Fa YE ; Hao WEN
Journal of Central South University(Medical Sciences) 2005;30(5):549-552
OBJECTIVE:
To observe the effect of cyclosporine and simulect mono or combination therapy on cardiac allo-transplantation in rats.
METHODS:
Recipients with allografts were treated with different doses of cyclosporine and/or simulect after cardiac allo-transplantation. Graft survival time was observed; the histopathological examination of graft tissues was performed; and levels of serum IL-2 and IL-4 were determined.
RESULTS:
Mono or combination therapy with cyclosporine and/or simulect increased the survival of cardiac allografts. With the prolongation of survival time of the grafts, the rejection of grafts was moderated. The serum IL-2 level increased in acute rejected grafts; the serum IL-4 level increased evidently in long survival grafts.
CONCLUSION
Cyclosporine and simulect have an effect in the prolongation of cardiac allograft survival in rats, and the combination therapy shows an evident synergistic effect.
Animals
;
Antibodies, Monoclonal
;
pharmacology
;
therapeutic use
;
Basiliximab
;
Combined Modality Therapy
;
Cyclosporine
;
pharmacology
;
therapeutic use
;
Female
;
Graft Rejection
;
immunology
;
Heart Transplantation
;
adverse effects
;
Immunosuppressive Agents
;
pharmacology
;
therapeutic use
;
Rats
;
Rats, Sprague-Dawley
;
Rats, Wistar
;
Recombinant Fusion Proteins
;
pharmacology
;
therapeutic use
3.Immune tolerance induced by combined heart-thymus transplantation with intrathymic inoculation of thymocytes in rats.
Hai-bo XIONG ; Sui-sheng XIA ; Zu-fa HUANG ; Hao WEN ; Qi-fa YE
Journal of Central South University(Medical Sciences) 2006;31(1):85-90
OBJECTIVE:
To explore the role of allo heart and thymus transplantation by intrathymic inoculation of thymocytes.
METHODS:
Wistar recipients were given intrathymic injection of allo thymocytes (2 x 10(7)) 14 days before the heart and/or thymus transplantation. Graft survival, histopathology, levels and mRNA expressions of IL-2, IL-4 in serum and cardiac-grafts were investigated.
RESULTS:
Heart transplantation and heart-thymus composite transplantation with the treatment of CysA for 7 or 14 days prolonged graft survival. Heart transplantation and heart-thymus composite transplantation with intrathymic thymocytes injection induced the long-term survival of allo-grafts transiently immunosuppressed with CysA; IL-4 maintained at high levels but IL-2 kept at low levels in grafts in long-term survivals.
CONCLUSION
Intrathymic inoculation of allo thymoctyes can induce immune tolerance for both cardiac transplantation and heart-thymus combined transplantation in rats. Thymus graft may play a role in the induction and maintenance of central tolerance.
Animals
;
Cell Transplantation
;
Female
;
Graft Rejection
;
prevention & control
;
Graft Survival
;
Heart Transplantation
;
Immune Tolerance
;
Interleukin-2
;
blood
;
Interleukin-4
;
blood
;
Rats
;
Rats, Sprague-Dawley
;
Rats, Wistar
;
Thymus Gland
;
cytology
;
transplantation
4.Immune tolerance induced by combined heart-thymus transplantation for heart allograft in rats.
Hai-Bo XIONG ; Zu-Fa HUANG ; Qi-Fa YE ; Sui-Sheng XIA
Journal of Central South University(Medical Sciences) 2007;32(1):47-53
OBJECTIVE:
To explore the role of combined heart-thymus transplantation for heart allograft in rats.
METHODS:
Vascularized heart-thymus combined transplantation was performed with microsurgical technique. Graft survival, histopathology, infiltration of CD4+, CD8+ T cells, level and mRNA expressions of IL-2 and IL-4 in the serum and cardiac grafts were investigated.
RESULTS:
Heart allograft in the controls had a survival time of (6.0+/-0.76) d. heart-thymus combined transplantation in non-thymectomized rats had a survival time of (6.88+/-0.64)d (P<0.05). Heart-thymus combined transplantation in thymectomized rats led to an evident survival time of (14.13+/-5.82)d (P<0.01) for cardiac graft, which further obtained long term survival after short course of treatment with cyclosporine. Pathologic lesion and infiltration of CD4+ and CD8+ T cells in cardiac grafts showed mitigated in the long term survival group. IL-2 level in the serum and cardiac grafts maintained low level in the long term survival group, whereas IL-4 maintained high level.
CONCLUSION
Whether thymectomized or not in recipient rats, heart-thymus combined transplantation has a positive effect to protect cardiac graft. Furthermore, in thymectomized rats heart-thymus combined transplantation may lead to evident survival prolongation of the heart grafts, which induces immune tolerance in short course of treatment with cyclosporine.
Animals
;
CD4-Positive T-Lymphocytes
;
immunology
;
CD8-Positive T-Lymphocytes
;
immunology
;
Cyclosporine
;
therapeutic use
;
Graft Survival
;
drug effects
;
immunology
;
Heart Transplantation
;
Immune Tolerance
;
drug effects
;
immunology
;
Immunosuppressive Agents
;
therapeutic use
;
Interleukin-2
;
blood
;
genetics
;
Interleukin-4
;
blood
;
genetics
;
Male
;
Rats
;
Rats, Sprague-Dawley
;
Rats, Wistar
;
Reverse Transcriptase Polymerase Chain Reaction
;
Thymectomy
;
Thymus Gland
;
transplantation
;
Time Factors
;
Transplantation Immunology
;
immunology
;
Transplantation, Homologous
5.Effect of mono and combination therapy with FTY720 and ICAM-1 mAb for mouse-to-rat cardiac xenotransplantation.
Hai-Bo XIONG ; Zu-Fa HUANG ; Qi-Fa YE ; Sui-Sheng XIA
Journal of Central South University(Medical Sciences) 2007;32(1):41-46
OBJECTIVE:
To observe the effect of FTY720 and ICAM-1 mAb mono and combination therapy in mouse-to-rat cardiac xenotransplantation.
METHODS:
Cardiac xenotransplantation was performed in abdominal site with micro-surgical technique. Recipients with xenografts were treated with different doses of FTY720 and/or ICAM-1 mAb. Graft survival, histopathology, infiltration of CD4+, and CD8+ T cells and levels of serum IL-2, IFN-gamma, IL-4, and IgM were investigated.
RESULTS:
Survival time of xenografts was (2.75+/- 0.43)d in the controls, survival of grafts treated with ICAM-1 mAb did not significantly improve. Treatment with large dose FTY720 led to a survival of (4.25+/- 0.71)d (P<0.01). Combination therapy with large dose FTY720 and ICAM-1 mAb achieved a significant prolongation of graft survival with (10.25+/- 2.12)d (P<0.01). Levels of serum IL-2, IFN-gamma and rat-anti-mouse IgM decreased in the combined therapy group. Pathologic lesion and infiltration of T cells in xenografts showed mitigated in the large dose combined therapy group. There was a significant negative correlation between the antibody level and the graft survival time (R=-0.754, P<0.01).
CONCLUSION
The combined therapy of FTY720 and ICAM-1 mAb can achieve a significant effect in the prolongation of heart xenograft survival and inhibition of xenoantibodies.
Animals
;
Antibodies, Monoclonal
;
therapeutic use
;
Dose-Response Relationship, Drug
;
Drug Therapy, Combination
;
Female
;
Fingolimod Hydrochloride
;
Graft Rejection
;
blood
;
etiology
;
prevention & control
;
Graft Survival
;
drug effects
;
Heart Transplantation
;
adverse effects
;
methods
;
Immunoglobulin M
;
blood
;
Immunosuppressive Agents
;
therapeutic use
;
Intercellular Adhesion Molecule-1
;
immunology
;
Interferon-gamma
;
blood
;
Interleukin-2
;
blood
;
Interleukin-4
;
blood
;
Mice
;
Mice, Inbred BALB C
;
Propylene Glycols
;
therapeutic use
;
Rats
;
Rats, Wistar
;
Sphingosine
;
analogs & derivatives
;
therapeutic use
;
Time Factors
;
Transplantation, Heterologous
6.Serum proteomics in patients with RAEB myelodysplastic syndromes.
Li-ye ZHONG ; Tian-hao LIU ; Yang-qiu LI ; Su-xia GENG ; Ze-sheng LU ; Jian-yu WENG ; Sui-jing WU ; Cheng-wei LUO ; Xin DU
Journal of Southern Medical University 2009;29(9):1799-1801
OBJECTIVETo screen the molecular markers for refractory anemia with excess blasts in transformation (RAEB) in myelodysplastic syndromes (MDS) by serum proteome profiling.
METHODSThe serum protein were isolated from patients with RAEB, acute myeloid leukemia or normal subjects by 2-dimensional electrophoresis (2-DE), and the electrophoresis gels were obtained to identify the differentially reacting protein spots. The replica gels of the differentially reacting proteins were analyzed to locate the matching protein spots, which were identified by peptide mass fingerprint based on matrix-assisted laser desorption/ionization time of-flight mass spectrometry (MALDI-TOF-MS) and database searching.
RESULTSSeven differentially expressed proteins in RAEB were found by 2-DE. Of the 7 proteins, 4 were identified by MALDI-TOF-MS to have significantly differential expression in RAEB, including dipeptidyl peptidase (DPP/CD26), polymerase (DNA directed) kappa, PRO2044 and an albumin-like protein.
CONCLUSION2-DE-based serum proteome profiling helps identify serum proteomic biomarkers related to MDS. DDP/CD26 has increased expression in the serum in RAEB subtype MDS, suggesting its possible role in advanced MDS.
Anemia, Refractory, with Excess of Blasts ; blood ; genetics ; Bone Marrow ; pathology ; DNA-Directed DNA Polymerase ; blood ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases ; blood ; Female ; Humans ; Male ; Middle Aged ; Myelodysplastic Syndromes ; blood ; classification ; genetics ; Proteomics
7.C-kit mutation in acute myeloid leukemia patients with AML1-ETO fusion gene and its clinical significance.
Su-Xia GENG ; Xin DU ; Jian-Yu WENG ; Xin HUANG ; Ze-Sheng LU ; Li-Ye ZHONG ; Rong GUO ; Sui-Jing WU ; Ping WU
Journal of Experimental Hematology 2013;21(4):839-842
This study was aimed to investigate the c-kit mutation in acute myeloid leukemia (AML) patients with AML1-ETO and analyze its relation with clinical and laboratorial features and prognosis. PCR and sequencing methods were used to detect the c-kit 17 exon mutations in 31 AML patients with AML1-ETO. The relation of the c-kit mutation with clinical features, results of laboratorial examination and prognosis of disease were analyzed. The results showed that the c-kit mutation was found in 14 out of 31 AML patients and the mutation frequency was 45.16%. Male patients had a higher incidence of c-kit mutation than that of female patients (P = 0.020). The proportion of patients with newly diagnosed white blood cell>10×10(9)/L and with extramedullary infiltration in mutated group were higher than those in unmutated group respectively. No significant difference was observed at the age (P = 0.437) and the rate of bone marrow blasts(P = 0.510) between the above mentioned two groups. The difference in complete remission rate (64.29% vs 80%, P = 0.344)and relapse rate (58.33% vs 21.43%, P = 0.054) between c-kit mutated and c-kit unmutated groups were not significant. While the c-kit mutated group had a significant higher death rate as compared with c-kit unmutated group (57.14% vs 20%, P = 0.039). It is concluded that the c-kit mutation is frequent in AML patients with AML1-ETO and the c-kit mutated patients have a poor prognosis. It is important to detect c-kit mutation in routine clinical practice for patient's risk stratification, evaluation of prognosis and selection of effective treatment.
Adolescent
;
Adult
;
Aged
;
Core Binding Factor Alpha 2 Subunit
;
genetics
;
DNA Mutational Analysis
;
Female
;
Humans
;
Leukemia, Myeloid, Acute
;
genetics
;
pathology
;
Male
;
Middle Aged
;
Mutation
;
Oncogene Proteins, Fusion
;
genetics
;
Prognosis
;
Proto-Oncogene Proteins c-kit
;
genetics
;
RUNX1 Translocation Partner 1 Protein
;
Treatment Outcome
;
Young Adult
8.Feasibility of balloon dilation with injectable calcium sulfate cement for tibial plateau fractures
Jin-Min CHEN ; Sui-Sheng CHEN ; Jing DING ; Bao-Quan XIA ; Xiao-Jia LUO ; Cheng-Hai LU ; Zhen-Keng YANG
Chinese Journal of Tissue Engineering Research 2018;22(18):2795-2799
BACKGROUND: The balloon dilatation technique plays an important role in the correction of kyphosis. A balloon catheter can enlarge the spinal cavity in kyphoplasty followed by injection of bone cement under low pressure to lay a foundation for the stability of the spine. OBJECTIVE: To explore the feasibility of balloon dilation with injectable calcium sulfate cement for tibial plateau fractures and to analyze its clinical effect. METHODS: Twenty-four upper tibia specimens of the adults were taken to make the Schatzker Ⅲ collapsed fracture model of the tibial plateau. Then, these specimens were randomized into three groups: the standard group was subjected to poking reduction with autologus bone grafting and screw internal fixation, the bone cement group was inflated with balloon dilatation followed by calcium sulfate cement injection, and the combined group was treated with fixation with cancellous bone screws and balloon dilatation followed by injection of calcium sulfate cement. The general situation of reduction and fixation was observed and the reduction effect was measured. RESULTS AND CONCLUSION: (1) Fixation effect in the model: All three models were well reset, and the average displacement of the standard group, the simple bone cement group and the bone cement screw group was (-0.22±0.62), (-0.23±0.67), and (-0.20±0.69) mm, respectively. There was no significant difference in the displacement between the three groups (P > 0.05). (2) Clinical application: One case of Schatzker type Ⅱ fracture of the left tibial plateau was treated with cancellous bone screw fixation and balloon dilatation followed by injection of calcium sulfate cement. X-ray results showed calcium sulfate cement was visible at 3 postoperative days. At 30 postoperative days, the patient presented with good joint range of motion, and the calcium sulfate was partially absorbed on the X-ray film. At 60 postoperative days, the patient appeared to have no joint extension disorder, and fracture healing and absorption of calcium sulfate as shown by X-rays. To conclude, the balloon dilation with injectable calcium sulfate cement for the treatment of tibial plateau fracture is feasible and has clinical value.
9.The protective effects on allografts of adeno-associated heme-oxygenase-1 gene therapy against chronic rejection injury.
Nian-Qiao GONG ; Dun-Feng DU ; Chong DONG ; Xi-Lin CHEN ; Hui GUO ; Jian-Sheng XIAO ; Wei-Jie ZHANG ; Zheng-Bin LIN ; Zhi-Shui CHEN ; Qi-Fa YE ; Sui-Sheng XIA
Chinese Journal of Surgery 2007;45(4):254-257
OBJECTIVETo investigate the protective effects on allografts and the possible mechanism of adeno-associated heme-oxygenase-1 (AdHO-1) gene therapy against chronic rejection injury.
METHODSEx vivo AdHO-1 gene therapy was performed in vascular and renal transplantation models. The structure and function, the expression of therapeutic genes and proteins, and the immune modulation were analyzed.
RESULTSAdHO-1 gene therapy protected renal transplant against chronic rejection, but the effect was not as remarkable as that in vascular transplant. The transfected empty vehicle aggravated chronic rejection damage in renal transplantation. AdHO-1 decreased the infiltration of macrophages and CD4(+) T cells.
CONCLUSIONSAdHO-1 gene therapy can lessen damage of chronic rejection in allografts. It plays roles by protecting transplants, down-regulating immune response and inducing immune deviation.
Adenoviridae ; genetics ; Animals ; Blood Vessels ; transplantation ; CD4 Lymphocyte Count ; Chronic Disease ; Genetic Therapy ; methods ; Genetic Vectors ; Graft Rejection ; etiology ; prevention & control ; Graft Survival ; Heme Oxygenase-1 ; genetics ; Kidney Transplantation ; adverse effects ; methods ; Macrophages ; pathology ; Male ; Rats ; Rats, Inbred Lew ; Transfection ; Transplantation, Homologous
10. Clinical Observation of Addition and Subtraction Therapy of Shenling Baizhu San to Antibiotic-associated Diarrhea with Spleen-stomach Deficiency and Cold Syndrome
Guang-yu ZHANG ; Qin-sheng ZHANG ; Xiao-na SUI ; Yu-feng ZHANG ; Zhen-hua LI ; Yong-liang LI ; Yan-mei WANG ; Zhi-xia SUN
Chinese Journal of Experimental Traditional Medical Formulae 2019;25(19):74-79
Objective:To discussed the clinical efficacy of addition and subtraction therapy of Shenling Baizhu San to antibiotic-associated diarrhea (AAD) with spleen-stomach deficiency and cold syndrome, and to investigate its effects on immune function and intestinal flora. Method:One hundred and fifteen patients were randomly divided into control group (57 cases) and observation group (58 cases) by random number table. Patients in control group got Shuangqi Ganjun Sanlian Huojun San, 2 bags/time, 2 times/days. Mengtuoshi San, 1 bag/time, 3 times/days, and they also got measures to prevent disturbance of water, electrolyte, acid-base balance and nutritional support. Based on the treatment in control group, patients in observation group also got addition and subtraction therapy of Shenling Baizhu San, 1 dose/day. The course of treatment was 7 days in both groups. Before and after treatment, scores of symptoms, intestinal secretory immunoglobulin (SIgA) levels, peripheral blood immunoglobulin A (IgA), G (IgG), M (IgM) and T lymphocyte subsets (CD3+, CD4+, CD8+and CD4+/CD8+). Detection of bacillus faccalis in feces before and after treatment and the bacteria were cultured to identify and count bifidobacterium, lactobacillus and enterococcus. In addition, diamine oxidase (DAO) and D-lactic acid levels were detected before and after treatment. Result:In rank sum test, clinical efficacy in observation group was better than that in control group (Z=2.268, P<0.01). Scores of main symptoms, secondary symptoms, spleen-stomach deficiency and cold syndrome were lower than those in control group(P<0.01). Levels of SIgA, IgA and IgG were significantly higher than those in the control group (P<0.01). Levels of CD3+, CD4+and CD4+/CD8+were higher than those in control group (P<0.05), while level of CD8+was lower than that in control group (P<0.05). Bacillus in faeces was significantly lower than that in control group(P<0.01). Count of enterococcus was lower than that in control group (P<0.05), while counts of bifidobacterium and lactobacillus were higher than those in control group (P<0.05). In addition, levels of DAO and D-lactic acid were significantly lower than those in control group (P<0.01). Conclusion:Based on conventional treatment, addition and subtraction therapy of Shenling Baizhu San can alleviate symptoms, improve clinical efficacy, improve immune function, regulate intestinal flora and promote the repair of intestinal mucosal barrier in the treatment of antibiotic-associated diarrhea (AAD) with spleen-stomach deficiency and cold syndrome.